Market Capitalization (Millions $) |
4,223 |
Shares
Outstanding (Millions) |
163 |
Employees |
- |
Revenues (TTM) (Millions $) |
1,106 |
Net Income (TTM) (Millions $) |
716 |
Cash Flow (TTM) (Millions $) |
181 |
Capital Exp. (TTM) (Millions $) |
0 |
Enact Holdings Inc
Watson Pharmaceuticals, Inc. completed the acquisition of Actavis Group. “Actavis,
Inc.” is a leading integrated global specialty pharmaceutical company engaged
in the development, manufacturing, marketing, sale and distribution of generic,
branded generic, brand, biosimilar and over-the-counter (“OTC”) pharmaceutical
products.
Company Address: 8325 Six Forks Road Raleigh 27615 NC
Company Phone Number: 846-4100 Stock Exchange / Ticker: NASDAQ ACT
ACT is expected to report next financial results on August 03, 2023. |
|
|